₹836.33
Below FV▲ +57.0% against the close used
Model range ₹58.43 – ₹1,617.23
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹58.43Fair value₹836.33Bull₹1,617.23
FairClose
52-week traded range
52W low ₹284.0552W high ₹650.60
The 52-week range is measured from the stored price history, not estimated.
Trading below the consensus fair value
Unichem Laboratories Ltd closed at ₹532.70, 36.3% below the consensus fair value of ₹836.33 drawn from 9 valuation models.
Financial DNA score 54/100 — Good. P/E of 31.1x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹453.55
-14.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹385.91
-27.6%
√(22.5 × EPS × BVPS)
EPS=35.91, BVPS=184.33 · outside Graham range (P/E 31.1, P/B 2.9) — asset-light, treat as a rough floor
Graham Formula
₹1,617.23
+203.6%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹1,281.99
+140.7%
EPS × 35.7x (sector P/E)
EPS=35.91, Sector P/E=35.7x
Peter Lynch (PEG)
₹897.75
+68.5%
EPS × Growth% (PEG = 1 is fair)
EPS=35.91, g=25%
EV/EBITDA
₹722.23
+35.6%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=3.14B
Book Value (P/B)
₹58.43
-89.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=184.33, ROE=3.2%, g=6%, r=10%
Reverse DCF
₹532.70
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 3.1% | Historical: 25%
Margin of Safety
₹701.00
+31.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=934.67, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.